MOH — authorised 10 October 2014
- Marketing authorisation holder: HELSINN HLTHCARE
- Status: likely_approved
🇮🇱 Akynzeo in Israel
MOH authorised Akynzeo on 10 October 2014
Marketing authorisation
Akynzeo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Akynzeo approved in Israel?
Yes. MOH authorised it on 10 October 2014.
Who is the marketing authorisation holder for Akynzeo in Israel?
HELSINN HLTHCARE holds the Israeli marketing authorisation.